CClinicalTrials.gg
CompletedNCT00716872SHUTi-CUpdated Feb 25, 2010

Improving the Sleep of Cancer Patients Using an Internet-Based Program

An interventional study of Sleep Healthy Using the Internet (SHUTi) and Hypnosis recordings in Cancer and Insomnia, sponsored by University of Virginia. Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2010-02-25.

Sponsored by University of Virginia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine whether an Internet-based program, Sleep Healthy Using the Internet (SHUTi, or "Shut-Eye"), can help to improve the sleep of people who are in remission from cancer and experiencing symptoms of insomnia.

Read the detailed description

The purpose of this study is to test the feasibility of using an Internet program to improve the sleep of cancer patients with insomnia. Participants will receive access to the Internet program (called SHUTi, or "Shut-Eye") as well as to self-hypnosis recordings designed to improve sleep. SHUTi provides an online, tailored educational program to individuals who are experiencing sleep difficulties, including those having difficulty falling asleep, waking in the middle of the night, and waking too early in the morning.

02

Conditions studied

  • Cancer
  • Insomnia

Keywords

  • cancer
  • sleep
  • insomnia
  • Internet
  • SHUTi
03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 594 are open to participants now.

This study's planned enrollment of 22 is below the median of 73 across 1,631 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

University of Virginia is the lead sponsor of 653 studies on the registry; 134 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 41 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age = At least 21 years old
  • Regular access to the Internet, including e-mail
  • Cancer patient

    • Any type of cancer (EXCEPT non-melanoma skin cancer)
    • In remission from any stage of cancer (active treatment completed at least one month prior to enrollment)
  • Insomnia diagnosis (combined from DSM-IV and ICSD):

    • Subjective complaints of poor sleep for at least 6 months
    • Sleep difficulties ≥3 nights/week
  • Difficulty falling asleep (≥30 minutes to fall asleep) OR
  • Difficulty staying asleep (≥30 minutes awake in the middle of the night)

    • ≤6.5 hours sleep/night
    • Poor sleep causes marked distress or significant impairment in daytime functioning (e.g. fatigue, performance deficits, mood disturbance)
  • Participant feels that the insomnia was caused/aggravated by cancer or cancer treatment

Exclusion criteria

Exclusion Criteria:

  • Having a sleep disorder other than insomnia (e.g. sleep apnea, RLS, narcolepsy, parasomnias)
  • Having a medical condition other than cancer that causes insomnia
  • Experiencing a psychiatric disturbance (major depression, psychosis)
  • Experiencing substance abuse
  • Currently undergoing psychotherapy or counseling
  • Changing sleep/anxiety/depression medication within the past month
  • Having an "unusual" sleep pattern

    • Normal bedtime is after 2am OR
    • Normal wake time is after 9am
  • Working as a shift worker (that is, having a schedule that requires working through the night)
  • Participants reports that she is pregnant or intending to get pregnant in the next 4 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
22 participants (estimated)

Study arms

  • Experimental
    ImmedSHUTi/ImmedHyp

    In the first part of the trial, participants are assigned to the Immediate SHUTi group; that is, they receive access to the SHUTi program right away. In the second part of the trial (3 months later), participants are assigned to the Immediate Hypnosis group; that is, they receive access to the Hypnosis recordings right away.

    Behavioral: Sleep Healthy Using the Internet (SHUTi) · Behavioral: Hypnosis recordings

  • Experimental
    ImmedSHUTi/DelayHyp

    In the first part of the trial, participants are assigned to the Immediate SHUTi group; that is, they receive access to the SHUTi program right away. In the second part of the trial (3 months later), participants are assigned to the Delayed Hypnosis group; that is, they receive access to the Hypnosis recordings at the end of the study.

    Behavioral: Sleep Healthy Using the Internet (SHUTi)

  • Experimental
    DelaySHUTi/ImmedHyp

    In the first part of the trial, participants are assigned to the Delayed SHUTi group; that is, they receive access to the SHUTi program at the end of the study. In the second part of the trial (3 months later), participants are assigned to the Immediate Hypnosis group; that is, they receive access to the Hypnosis recordings right away.

    Behavioral: Hypnosis recordings

  • No intervention
    DelaySHUTi/DelayHyp

    In the first part of the trial, participants are assigned to the Delayed SHUTi group; that is, they receive access to the SHUTi program at the end of the study. In the second part of the trial (3 months later), participants are assigned to the Delayed Hypnosis group; that is, they receive access to the Hypnosis recordings at the end of the study.

Interventions

  • BehavioralSleep Healthy Using the Internet (SHUTi)

    SHUTi is an Internet program based on cognitive-behavioral therapy for insomnia (CBT-I). Users complete daily online sleep diaries in addition to receiving weekly access to six interactive "Cores" of information. As they progress through the program, users receive tailored instructions for how to improve their sleep.

  • BehavioralHypnosis recordings

    Subjects listen to self-hypnosis recordings designed to improve their disturbed sleep.

06

What researchers measure

Primary outcomes

  1. Insomnia Severity Index (ISI)

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

  2. Sleep Diary: Sleep Efficiency

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

  3. Sleep Diary: Total Sleep Time

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

Secondary outcomes

  1. Sleep Diary: Sleep Onset Latency (SOL)

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

  2. Sleep Diary: Wake After Sleep Onset (WASO)

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

  3. Sleep Diary: Number of Nighttime Awakenings

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

  4. Hospital Depression and Anxiety Scale

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

  5. Pain scale

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

  6. Multidimensional Fatigue Symptom Inventory

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

  7. Quality of Life (SF-12 Health Survey)

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

  8. Hot flashes

    Time frame: prior to intervention, after SHUTi use, after Hypnosis use

07

Study locations

1 site
  • University of Virginia Department of Psychiatry & Neurobehavioral Sciences
    Charlottesville, Virginia 22908, United States
08

References and documents

Publications

  • Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol. 2005 Sep 1;23(25):6083-96. doi: 10.1200/JCO.2005.09.548. PubMed 16135475 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00716872
Lead sponsor
University of Virginia
First posted
Jul 16, 2008
Start date
Jul 2008
Primary completion
Nov 2009
Completion
Nov 2009
Last update
Feb 25, 2010

Study contacts

Lee M Ritterband, Ph.D.
principal investigator · University of Virginia
Lora D Baum, Ph.D.
principal investigator · University of Virginia
Elaine T Bailey, Ph.D.
study director · University of Virginia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion